New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Worm tablet could be repurposed as brain cancer treatment

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac
Hematology&Oncology August 20,2026
Worm tablet could be repurposed as brain cancer treatment

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac
Hematology&Oncology August 20,2026
Serious infection risks linked to targeted cancer therapies

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec
Hematology&Oncology August 20,2026
Serious infection risks linked to targeted cancer therapies

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec
Hematology&Oncology August 20,2026
Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted
Hematology&Oncology August 20,2026
Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted
Hematology&Oncology August 20,2026
Aspirin may unmask silent bladder cancer by triggering bleeding

Aspirin may unmask silent bladder cancer by triggering bleeding

byWileyCredit: Unsplash/CC0 Public DomainThe presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause m
Hematology&Oncology August 20,2026
Aspirin may unmask silent bladder cancer by triggering bleeding

Aspirin may unmask silent bladder cancer by triggering bleeding

byWileyCredit: Unsplash/CC0 Public DomainThe presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause m
Hematology&Oncology August 20,2026
Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome
Hematology&Oncology August 20,2026
Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome
Hematology&Oncology August 20,2026
Alcohol linked to higher risk across multiple cancers, even below one drink daily

Alcohol linked to higher risk across multiple cancers, even below one drink daily

byInstitute for Health Metrics and EvaluationCredit: Pixabay from PexelsA new study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington provides the most compre
Hematology&Oncology August 19,2026
Alcohol linked to higher risk across multiple cancers, even below one drink daily

Alcohol linked to higher risk across multiple cancers, even below one drink daily

byInstitute for Health Metrics and EvaluationCredit: Pixabay from PexelsA new study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington provides the most compre
Hematology&Oncology August 19,2026
Blood test spots 14 proteins that predict lung cancer risk up to five years early

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start
Hematology&Oncology August 19,2026
Blood test spots 14 proteins that predict lung cancer risk up to five years early

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start
Hematology&Oncology August 19,2026
Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex
Hematology&Oncology August 19,2026
Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex
Hematology&Oncology August 19,2026
New breakthrough in developing more personalized treatments for lung cancer

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred
Hematology&Oncology August 19,2026
New breakthrough in developing more personalized treatments for lung cancer

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred
Hematology&Oncology August 19,2026
Creatine may supercharge immune cells that are key to fighting cancer

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th
Hematology&Oncology August 19,2026
Creatine may supercharge immune cells that are key to fighting cancer

Creatine may supercharge immune cells that are key to fighting cancer

by Tiare Dunlap,University of California, Los AngelesAn artistic rendering of a human dendritic cell. Credit: Don Bliss & Sriram Subramaniam, National Cancer InstituteCreatine, the organic acid th
Hematology&Oncology August 19,2026
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com